Molecular methods for rapid detection of aneuploidy

• Autorzy: Dudarewicz L , Holzgreve W , Jeziorowska A , Jakubowski L , Zimmermann B
• Języki publikacji: EN

Abstrakty

EN

Rapid molecular biological methods for prenatal diagnosis of the most common aneuploidies, collectively known as rapid aneuploidy testing, are compared in this review. We discuss methodological problems and limitations of these various methods. All these techniques are believed to be accurate and carry a low risk of misdiagnosis, but they differ in terms of labour-intensity and amenability to automation and high throughput testing. The question how to apply them safely and economically in a clinical setting has not been answered yet. The discussed techniques are so far not used as stand-alone tests, but some of them are routinely applied as a preliminary test that shortens the waiting time for classic cytogenetic karyotyping. In the future, mainly because of economical reasons, these methods may replace cytogenetics in the category of patients who make up the majority of those currently offered prenatal karyotyping: patients with moderately increased risk and no abnormalities detected by ultrasound.

Słowa kluczowe

EN

rapid molecular biological method; screening; DNA analysis; prenatal diagnosis; aneuploidy; fetus; molecular method

• Wydawca: -
• Czasopismo: Journal of Applied Genetics
• Rocznik: 2005
• Tom: 46
• Numer: 2
• Opis fizyczny: p.207-215,fig.,ref.

Twórcy

autor

Dudarewicz L

• Department of Medical Genetics, Polish Mother's Memorial Hospital, Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland

autor

Holzgreve W

• Laboratory for Prenatal Medicine, University Women's Hospital, University of Basel, Basel, Switzerland

autor

Jeziorowska A

• Institute of Endocrinology and Radiation Therapy, Medical University in Łódź, Department of Medical Genetics, Polish Mother's Memorial Hospital - Research Institute, Łódź, Poland

autor

Jakubowski L

• Department of Medical Genetics, Polish Mother's Memorial Hospital, Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland

autor

Zimmermann B

• Laboratory for Prenatal Medicine, University Women's Hospital, University of Basel, Basel, Switzerland

Bibliografia

• Adinolfi M, Sherlock J, Pertl B, 1995. Rapid detection of selected aneuploidies by quantitative fluorescent PCR. Bioessays 17: 661-664.
• Eiben B, Trawicki W, Hammans W, Goebel R, Pruggmayer M, Epplen JT, 1999. Rapid prenatal diagnosis of aneuploidies in uncultured amniocytes by fluorescence in situ hybridization. Evaluation of >3,000 cases. Fetal Diagn Ther 14: 193-197.
• Findlay I, Matthews P, Toth T, Quirke P, Papp Z, 1998. Same day diagnosis of Down’s syndrome and sex in single cells using multiplex fluorescent PCR. Mol Pathol 51: 164-167.
• Langlois RG, Yu LC, Gray JW, Carrano AV, 1982. Quantitative karyotyping of human chromosomes by dual beam flow cytometry. Proc Natl Acad Sci USA 79: 7876-7880.
• Larose C, Massoc P, Hillion Y, Bernard JP, Ville Y, 2003. Comparison of fetal nasal bone assessment by ultrasound at 11-14 weeks and by postmortem X-ray in trisomy 21: a prospective observational study. Ultrasound Obstet Gynecol. 22: 27-30.
• Leung WC, Lam YH, Wong Y, Lau ET, Tang MH, 2002. The effect of fast reporting by amnio-PCR on anxiety levels in women with positive biochemical screening for Down syndrome: a randomized controlled trial. Prenat Diagn 22: 256-259.
• Levett LJ, Liddle S, Meredith R, 2001. A large-scale evaluation of amnio-PCR for the rapid prenatal diagnosis of fetal trisomy. Ultrasound Obstet Gynecol 17: 115-118.
• Liu W, Saint DA, 2002. Validation of a quantitative method for real-time PCR kinetics. Biochem Biophys Res Commun 294: 347-353.
• Mann K, Ogilvie CM, 2001. Prenatal detection of chromosome disorders. Lancet. 358: 1646.
• Mutter GL, Pomponio RJ, 1991. Molecular diagnosis of sex chromosome aneuploidy using quantitative PCR Nucleic Acids Research, 19(15) 4203-4207
• Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K 1992. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304: 867-869.
• Nicolaides KH, 2003. Screening for chromosomal defects. Ultras. Obstet. Gynecol. 21: 313-321.
• Pertl B, Pieber D, Lercher-Hartlieb A, Orescovic I, Haeusler M, Winter R, Kroisel P, Adinolfi M, 1999. Rapid prenatal diagnosis of aneuploidy by quantitative fluorescent PCR on fetal samples from mothers at high risk for chromosome disorders. Mol Hum Reproduction 5: 1176-1179..
• Pfaffl, M. W, 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 29: e45.
• Pont-Kingdon G., Lyon E, 2003. Rapid detection of aneuploidy (trisomy 21) by allele quantification combined with melting curves analysis of single-nucleotide polymorphism loci. Clin Chem 49: 1087.
• Schmidt W, Jendemy J., Hecher K, 2000. Detection of aneuploidy in chromosomes X, Y, 13, 18 and 21 by QF-PCR in 662 selected pregnancies at risk. Mol Hum Reproduction 6: 855-860.
• Schouten JP, McElgun CJ, Waaijer R, Zwijnenburg D, Diepvens P, Pals G, 2002. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucl Ac Res 30: e57.
• Sellner LN, Taylor GR, 2004. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 23: 413—419.
• Slater HR, Bruno DL, Ren H, Pertile M, Schouten JP, Choo KH, 2003. Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). J Med Genet. 40: 907-912
• Sohn C, Tercanli S, Holzgreve W, 2003. Ultraschall in Gynaekologie und Geburtshilfe. Thieme, Stuttgart
• Spencer K, Aitken DA, Crossley JA, McCaw G, Berry E, Anderson R, Connor JM, Macri JN, 1994. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem 31: 447-454.
• Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH, 2003. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three year’s prospective experience. BJOG. 110:281-286.
• Toth T, Findlay I, Papp C, 1998. Prenatal detection of trisomy 21 and 18 from amniotic fluid by quantitative fluorescent polymerase chain reaction. J Medical Genetics 35: 126-129.
• Trask BJ, 1991. Fluorescence in situ hybridization: applications in cytogenetics and gene mapping. Trends Genet 7: 149-154.
• Ward BE, Gersen SL, Carelli MP, McGuire NM, Dackowski WR, Weinstein M, et al. 1993. Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens. Am J Hum Genet 52: 854-865.
• Weinans MJ, Huijssoon AM, Tymstra T, Gerrits MC, Beekhuis JR, Mantingh A, 2000. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy. Prenat Diagn 20: 705-708.
• Zhong XY, Holzgreve W, Hahn S, 2000. Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. BJOG 107: 766-769.
• Zimmermann B, Holzgreve W, Wenzel F, Hahn S. 2002. Novel real-time quantitative PCR test for trisomy 21. Clin Chem 48: 362-363.